It will also be important to determine whether there are changes in ADM expression or in the activity of its downstream signaling components in pathologies known to increase ADM levels such as diabetic retinopathy, glaucoma, retinitis pigmentosa, or uveitis. This evidence concerns the gene ADM and uveitis.